PSTV
Plus Therapeutics, Inc.$5.83-0.16 (-2.67%)Prev Close$5.99·MCap$14.5M·P/E—·Vol99.9K·Yield—
▲
Buys (12M)
2
$64.0K
▼
Sells (12M)
0
$0.00
◆
Net Activity
Net Buyer
$64.0K
●
Active Insiders
2
last 12 mo
Over the past 12 months, insider activity at Plus Therapeutics, Inc. (PSTV) has been exclusively buying, with 2 insider purchases totaling $64.0K and 0 insider sales totaling $0.00. The most recent insider transaction was by Sims Andrew John Hugh MacIntyre (Chief Financial Officer), who purchased $10.2K worth of shares on Nov 4, 2025. Plus Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $14.5M.
PSTV Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 4, 2025 | Sims Andrew John Hugh MacIntyre | Chief Financial Officer | Buy | 20,000 | $0.51 | $10.2K0.8% OS | 0 |
| Aug 22, 2025 | Lenk Robert P | Director | Buy | 110,000 | $0.49 | $53.8K4.5% OS | 0 |
| Sep 17, 2024 | Hawkins Richard J | Buy | 4,000 | $1.50 | $6.0K | 15,188+36% | |
| Sep 16, 2024 | Hawkins Richard J | Buy | 6,285 | $1.35 | $8.5K | 11,188+128% | |
| Sep 13, 2024 | Clowes Howard | Buy | 5,000 | $1.34 | $6.7K | 26,497 | |
| Sep 13, 2024 | Petersen Greg | Buy | 12,500 | $1.35 | $16.9K0.5% OS | 48,921+34% | |
| Sep 11, 2024 | HEDRICK MARC H | Chief Executive Officer | Buy | 8,000 | $1.23 | $9.8K | 20,425+64% |
| Sep 11, 2024 | Sims Andrew John Hugh MacIntyre | Chief Financial Officer | Buy | 4,098 | $1.27 | $5.2K | 9,815+72% |
| May 10, 2024 | Clowes Howard | Buy | 9,804 | $2.04 | $20.0K | 21,497+84% | |
| May 10, 2024 | Hawkins Richard J | Buy | 4,902 | $2.04 | $10.0K | 4,903New Position | |
| May 10, 2024 | HEDRICK MARC H | Chief Executive Officer | Buy | 12,255 | $2.04 | $25.0K0.5% OS | 12,425New Position |
| May 10, 2024 | Lenk Robert P | Buy | 4,167 | $2.04 | $8.5K | 29,327 | |
| May 10, 2024 | Petersen Greg | Buy | 12,255 | $2.04 | $25.0K0.5% OS | 36,421+51% | |
| May 10, 2024 | Sims Andrew John Hugh MacIntyre | Chief Financial Officer | Buy | 4,902 | $2.04 | $10.0K | 5,717+601% |
| Dec 15, 2023 | HEDRICK MARC H | Chief Executive Officer | Sell | 2,068 | $1.96 | $4.1K | 170-92% |
| Nov 17, 2023 | Lenk Robert P | Director | Buy | 2,000 | $1.86 | $3.7K | 25,160 |
| Nov 15, 2023 | Lenk Robert P | Director | Buy | 6,000 | $1.44 | $8.6K | 23,160+35% |
| Nov 13, 2023 | Lenk Robert P | Director | Buy | 9,199 | $1.62 | $14.9K | 17,160+116% |
| Nov 8, 2023 | Lenk Robert P | Director | Buy | 7,395 | $1.61 | $11.9K | 7,961New Position |
| Sep 15, 2023 | Clowes Howard | Director | Buy | 6,993 | $1.43 | $10.0K | 11,693+149% |
| Sep 12, 2023 | Petersen Greg | Director | Buy | 20,000 | $1.70 | $34.1K0.8% OS | 24,166+480% |
| Jun 8, 2023 | Clowes Howard | Director | Buy | 1,000 | $3.98 | $4.0K | 4,700+27% |
| May 4, 2023 | Clowes Howard | Director | Buy | 2,500 | $3.64 | $9.1K | 3,700+208% |
| Jan 4, 2023 | Lenk Robert P | Director | Sell | 1,500 | $0.31 | $472.05 | 8,500 |
| Jun 16, 2022 | HEDRICK MARC H | Chief Executive Officer | Buy | 5,000 | $0.65 | $3.2K | 33,580 |
| Jun 6, 2022 | Clowes Howard | Director | Buy | 15,000 | $0.57 | $8.6K0.6% OS | 18,000+500% |
| May 19, 2022 | Petersen Greg | Director | Buy | 30,000 | $0.55 | $16.5K1.2% OS | 62,500+92% |
| Apr 28, 2022 | HEDRICK MARC H | Chief Executive Officer | Buy | 2,500 | $0.68 | $1.7K | 28,580 |
| Apr 27, 2022 | HEDRICK MARC H | Chief Executive Officer | Buy | 5,000 | $0.69 | $3.5K | 26,080 |
| Apr 27, 2022 | Sims Andrew John Hugh MacIntyre | Chief Financial Officer | Buy | 3,000 | $0.67 | $2.0K | 12,230+33% |
| Mar 3, 2022 | Sims Andrew John Hugh MacIntyre | Chief Financial Officer | Buy | 2,000 | $1.10 | $2.2K | 9,230+28% |
| Nov 4, 2021 | Sims Andrew John Hugh MacIntyre | Chief Financial Officer | Buy | 1,000 | $1.86 | $1.9K | 7,230 |
| Oct 28, 2021 | Petersen Greg | Director | Buy | 12,500 | $1.72 | $21.5K0.5% OS | 32,500+63% |
| Oct 27, 2021 | HEDRICK MARC H | Chief Executive Officer | Buy | 2,500 | $1.66 | $4.1K | 21,080 |
| Oct 27, 2021 | Sims Andrew John Hugh MacIntyre | Chief Financial Officer | Buy | 2,000 | $1.67 | $3.3K | 6,230+47% |
| Sep 15, 2021 | Lenk Robert P | Director | Buy | 7,000 | $1.86 | $13.0K | 10,000+233% |
| Jul 29, 2021 | Sims Andrew John Hugh MacIntyre | Chief Financial Officer | Buy | 4,230 | $1.98 | $8.4K | 4,230 |
| May 3, 2021 | HEDRICK MARC H | Chief Executive Officer | Buy | 2,183 | $2.28 | $5.0K | 18,580 |
| Mar 5, 2021 | HEDRICK MARC H | Chief Executive Officer | Buy | 2,500 | $2.50 | $6.3K | 16,397 |
| Mar 4, 2021 | Clowes Howard | Director | Buy | 3,000 | $2.42 | $7.3K | 3,000 |
PSTV Insider Buying Activity
The following table shows recent insider purchases of Plus Therapeutics, Inc. (PSTV) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 4, 2025 | Sims Andrew John Hugh MacIntyre | Chief Financial Officer | Buy | 20,000 | $0.51 | $10.2K0.8% OS | 0 |
| Aug 22, 2025 | Lenk Robert P | Director | Buy | 110,000 | $0.49 | $53.8K4.5% OS | 0 |
| Sep 17, 2024 | Hawkins Richard J | Buy | 4,000 | $1.50 | $6.0K | 15,188+36% | |
| Sep 16, 2024 | Hawkins Richard J | Buy | 6,285 | $1.35 | $8.5K | 11,188+128% | |
| Sep 13, 2024 | Clowes Howard | Buy | 5,000 | $1.34 | $6.7K | 26,497 | |
| Sep 13, 2024 | Petersen Greg | Buy | 12,500 | $1.35 | $16.9K0.5% OS | 48,921+34% | |
| Sep 11, 2024 | HEDRICK MARC H | Chief Executive Officer | Buy | 8,000 | $1.23 | $9.8K | 20,425+64% |
| Sep 11, 2024 | Sims Andrew John Hugh MacIntyre | Chief Financial Officer | Buy | 4,098 | $1.27 | $5.2K | 9,815+72% |
| May 10, 2024 | Clowes Howard | Buy | 9,804 | $2.04 | $20.0K | 21,497+84% | |
| May 10, 2024 | Hawkins Richard J | Buy | 4,902 | $2.04 | $10.0K | 4,903New Position | |
| May 10, 2024 | HEDRICK MARC H | Chief Executive Officer | Buy | 12,255 | $2.04 | $25.0K0.5% OS | 12,425New Position |
| May 10, 2024 | Lenk Robert P | Buy | 4,167 | $2.04 | $8.5K | 29,327 | |
| May 10, 2024 | Petersen Greg | Buy | 12,255 | $2.04 | $25.0K0.5% OS | 36,421+51% | |
| May 10, 2024 | Sims Andrew John Hugh MacIntyre | Chief Financial Officer | Buy | 4,902 | $2.04 | $10.0K | 5,717+601% |
| Nov 17, 2023 | Lenk Robert P | Director | Buy | 2,000 | $1.86 | $3.7K | 25,160 |
| Nov 15, 2023 | Lenk Robert P | Director | Buy | 6,000 | $1.44 | $8.6K | 23,160+35% |
| Nov 13, 2023 | Lenk Robert P | Director | Buy | 9,199 | $1.62 | $14.9K | 17,160+116% |
| Nov 8, 2023 | Lenk Robert P | Director | Buy | 7,395 | $1.61 | $11.9K | 7,961New Position |
| Sep 15, 2023 | Clowes Howard | Director | Buy | 6,993 | $1.43 | $10.0K | 11,693+149% |
| Sep 12, 2023 | Petersen Greg | Director | Buy | 20,000 | $1.70 | $34.1K0.8% OS | 24,166+480% |
| Jun 8, 2023 | Clowes Howard | Director | Buy | 1,000 | $3.98 | $4.0K | 4,700+27% |
| May 4, 2023 | Clowes Howard | Director | Buy | 2,500 | $3.64 | $9.1K | 3,700+208% |
| Jun 16, 2022 | HEDRICK MARC H | Chief Executive Officer | Buy | 5,000 | $0.65 | $3.2K | 33,580 |
| Jun 6, 2022 | Clowes Howard | Director | Buy | 15,000 | $0.57 | $8.6K0.6% OS | 18,000+500% |
| May 19, 2022 | Petersen Greg | Director | Buy | 30,000 | $0.55 | $16.5K1.2% OS | 62,500+92% |
| Apr 28, 2022 | HEDRICK MARC H | Chief Executive Officer | Buy | 2,500 | $0.68 | $1.7K | 28,580 |
| Apr 27, 2022 | HEDRICK MARC H | Chief Executive Officer | Buy | 5,000 | $0.69 | $3.5K | 26,080 |
| Apr 27, 2022 | Sims Andrew John Hugh MacIntyre | Chief Financial Officer | Buy | 3,000 | $0.67 | $2.0K | 12,230+33% |
| Mar 3, 2022 | Sims Andrew John Hugh MacIntyre | Chief Financial Officer | Buy | 2,000 | $1.10 | $2.2K | 9,230+28% |
| Nov 4, 2021 | Sims Andrew John Hugh MacIntyre | Chief Financial Officer | Buy | 1,000 | $1.86 | $1.9K | 7,230 |
| Oct 28, 2021 | Petersen Greg | Director | Buy | 12,500 | $1.72 | $21.5K0.5% OS | 32,500+63% |
| Oct 27, 2021 | HEDRICK MARC H | Chief Executive Officer | Buy | 2,500 | $1.66 | $4.1K | 21,080 |
| Oct 27, 2021 | Sims Andrew John Hugh MacIntyre | Chief Financial Officer | Buy | 2,000 | $1.67 | $3.3K | 6,230+47% |
| Sep 15, 2021 | Lenk Robert P | Director | Buy | 7,000 | $1.86 | $13.0K | 10,000+233% |
| Jul 29, 2021 | Sims Andrew John Hugh MacIntyre | Chief Financial Officer | Buy | 4,230 | $1.98 | $8.4K | 4,230 |
| May 3, 2021 | HEDRICK MARC H | Chief Executive Officer | Buy | 2,183 | $2.28 | $5.0K | 18,580 |
| Mar 5, 2021 | HEDRICK MARC H | Chief Executive Officer | Buy | 2,500 | $2.50 | $6.3K | 16,397 |
| Mar 4, 2021 | Clowes Howard | Director | Buy | 3,000 | $2.42 | $7.3K | 3,000 |
PSTV Insider Selling Activity
The following table shows recent insider sales of Plus Therapeutics, Inc. (PSTV) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Dec 15, 2023 | HEDRICK MARC H | Chief Executive Officer | Sell | 2,068 | $1.96 | $4.1K | 170-92% |
| Jan 4, 2023 | Lenk Robert P | Director | Sell | 1,500 | $0.31 | $472.05 | 8,500 |
PSTV Insiders
Similar Stocks to PSTV
VRTX
Vertex Pharmaceuticals Incorporated
$429.47+0.81%
$111.71B
REGN
Regeneron Pharmaceuticals, Inc.
$734.06-1.39%
$77.87B
ALNY
Alnylam Pharmaceuticals, Inc.
$303.44-1.64%
$41.24B
INSM
Insmed Incorporated
$135.11-0.64%
$30.79B
RVMD
Revolution Medicines, Inc.
$144.62+9.92%
$29.51B
UTHR
United Therapeutics Corporation
$566.69+0.03%
$25.13B
MRNA
Moderna, Inc.
$47.16-3.17%
$21.42B
RPRX
Royalty Pharma plc
$49.40-0.50%
$21.20B